Connect Sign In
LabMind podcasts
Peng Li, MD, PhD, ARUP medical director, seeks to increase awareness to the newly discovered VEXAS syndrome with a recently published blog and paper. |
December 6, 2024 | Next generation sequencing (NGS) testing detects UBA1 gene mutations, which are essential for the diagnosis of VEXAS syndrome and concurrent hematologic neoplasms. |
Visit booth #2455 at the American Society of Hematopathology (ASH) Annual Meeting and Exposition to speak with ARUP hematopathologists and learn about the latest in laboratory testing for hematologic diseases. |
December 4, 2024 |
ARUP Will Showcase Advances in Hematopathology at the 66th ASH Annual Meeting and Exposition ARUP medical directors will present key hematopathology research at the 66th ASH Annual Meeting, including developments in systemic mastocytosis treatment and testing for myeloid malignancy mutations. |
The 38th Annual Park City Anatomic Pathology Update offers an opportunity for community pathologists to connect with experts and engage in discussion of practical topics and updates. |
November 27, 2024 |
Why Community Pathologists Attend the Park City Anatomic Pathology Update Year After Year ARUP Laboratories will host the Park City Anatomic Pathology Update from February 9–13, 2025. The event will feature topics on gastrointestinal (GI), pancreatic, and hepatobiliary pathology. |
Presentations by ARUP medical directors and scientists at AMP 2024 included timely topics in molecular pathology such as automated DNA extraction. Melanie Mallory, MS, pictured above, a lead bioinformatics scientist at ARUP, presented a poster related to the prediction of viral loads for cytomegalovirus. |
November 26, 2024 |
ARUP Research Highlighted at the Association for Molecular Pathology 2024 Annual Meeting and Expo ARUP medical directors and scientists presented key molecular pathology advancements at AMP 2024 on topics such as viral load prediction, automated DNA extraction, and parasite detection. |
|
November 19, 2024 |
A New Edition of Magnify Is Available and Focuses on the FDA’s Rule To Regulate Lab-Developed Tests This edition features interviews with company leaders describing ARUP’s approaches to comply with the FDA’s rule and a video about how ARUP helped a family on a rare disease diagnostic journey. |
Michelle Tarver, MD, PhD, director of the FDA’s Center for Devices and Radiological Health (CDRH), and Jeff Shuren, MD, JD, CDRH director emeritus, appeared virtually at the Utah Life Sciences Summit. |
November 18, 2024 | FDA leaders answered questions on artificial intelligence (AI), international regulations, and representation in clinical trials during the Utah Life Sciences Summit. |
ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine We accelerate groundbreaking diagnostic and prognostic technologies to drive life-changing innovation. Our large, single-site operation and renowned quality framework, combined with our extensive expertise, provide an ideal incubator to advance custom projects for innovative partners. The Sherrie Perkins Research and Innovation Collaboration Grant The Sherrie Perkins Research and Innovation Collaboration Grant funds cutting-edge research in laboratory medicine.
ARUP Newsroom
Live Chat